Nemes Rush Group LLC Astrazeneca PLC Transaction History
Nemes Rush Group LLC
- $728 Billion
- Q2 2024
A detailed history of Nemes Rush Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Nemes Rush Group LLC holds 100 shares of AZN stock, worth $8,575. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 559
82.11%
Holding current value
$8,575
Previous $37.9 Million
79.41%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,331Shares Held
490MCall Options Held
4.99MPut Options Held
3.19M-
Price T Rowe Associates Inc Baltimore, MD64.9MShares$5.57 Billion0.61% of portfolio
-
Primecap Management CO Pasadena, CA42.6MShares$3.65 Billion2.44% of portfolio
-
Wellington Management Group LLP Boston, MA40.6MShares$3.48 Billion0.58% of portfolio
-
Capital International Investors Los Angeles, CA36.7MShares$3.15 Billion0.6% of portfolio
-
Franklin Resources Inc San Mateo, CA17.6MShares$1.51 Billion0.44% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $266B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...